جستجوی استاد راهنمای دانشگاهی

• Mental Health
• Adolescent Health
• Pain Management
• +۳ مورد دیگر

Elise Solbu Roalsø serves as a Research Fellow at the Department of Nursing and Health Promotion within the Faculty of Health Sciences at Oslo Metropolitan University. Based at Pilestredet 32 in Oslo, she functions as Study Leader for Research Area 8 and actively contributes to the Mental Health Research Group, with primary contact via elise.solbu.roalso@oslomet.no and mobile +47 932 18 125. Her research concentrates on adolescent mental health intersections with pharmacological practices, specifically examining pain management and over-the-counter analgesic usage patterns in youth populations. Methodologically, she employs cognitive assessment tools like dot-probe tasks and advanced statistical approaches including network analysis to investigate relationships between self-medication behaviors and psychological symptoms such as attentional biases, anxiety, and depression. Recent publications (2024-2025) reveal a cohesive research trajectory analyzing how analgesic consumption correlates with neuropsychological markers in adolescents and young women. Her work bridges pharmacology, cognitive psychology, and public health through interdisciplinary collaborations with researchers like Sandra Klonteig and Rune Jonassen across Scandinavian institutions. As Study Leader for Research Area 8, Roalsø directs the active "Pain, youth and self-medication (SUS)" project which systematically explores adolescent pain experiences and medication behaviors. Her position within the Mental Health Research Group facilitates cross-departmental initiatives focused on improving youth health outcomes through evidence-based interventions targeting self-medication practices.

• Clinical Bioinformatics
• Antimicrobial Resistance (AMR)
• Nanopore Sequencing
• +۳ مورد دیگر

Professor Ahmad Rafi is a faculty member in the Department of Clinical Bioinformatics at UiT The Arctic University of Norway, located in Tromsø. He leads research focused on rapid clinical diagnostics of bacterial infections and antimicrobial resistance (AMR), leveraging advanced technologies like nanopore sequencing and machine learning. His work emphasizes One Health perspectives, integrating human, animal, and environmental health domains. Research Interests: Development of rapid diagnostic tools for AMR and pathogen identification Integration of genomic sequencing (WGS) and real-time taxonomic analysis Optimization of clinical workflows for sepsis and urosepsis management Multi-omic approaches combining quantitative phase microscopy and machine learning Recent Publications Highlight: His team has achieved diagnostic turnaround times as low as 4–9 hours using nanopore sequencing for sepsis and urinary tract infections. Innovations include culture-independent methods and SERS nanowire chips for strain-level bacterial classification. Advising & Grants: While specific student names or grant details aren’t listed, his involvement in projects like AMR-Educate reflects collaborative efforts in education and innovation around antimicrobial resistance. Labs/Teams: Active member of the Clinical Bioinformatics Research Group, contributing to translational research bridging computational methods with clinical applications.

Lars Herfindalمشاهده پروفایل

استاد

• Nanomedicine
• Anti-cancer Therapy
• Natural Products Research
• +۳ مورد دیگر

Lars Herfindal is a Professor at the University of Bergen, affiliated with Clinical Institute 2. His research focuses on nanomedicine, anti-cancer therapies, and the discovery of bioactive compounds from natural sources. He leads projects on drug delivery systems, particularly liposomal formulations and cyclodextrin nanoparticles, emphasizing selective cytotoxicity in leukemia and other cancers. Herfindal has pioneered the exploration of cyanobacterial and plant-derived natural products for their anticancer and antimicrobial properties. He collaborates extensively, supervising students in pharmacology, biochemistry, and biomedical engineering. His work integrates zebrafish models, high-content imaging, and nanotechnology to advance personalized cancer treatments. Notable contributions include studies on iodinin, phenazine derivatives, and graphene-based drug carriers. Herfindal’s research also addresses complement system activation by monoclonal antibodies and the role of AXL in breast cancer stemness. He is actively involved in drug repurposing, such as chlorpromazine encapsulation, and has developed novel software tools for in vivo cell analysis. Education: PhD in Biomedicine (2006, University of Bergen) Key Research Themes: Leukemia treatment, natural product drug discovery, nanocarrier systems, marine biotechnology. Herfindal’s lab collaborates with institutions like Haukeland University Hospital and University of Helsinki, advancing translational research in oncology and pharmacology. His publications span over 150 peer-reviewed articles, emphasizing interdisciplinary approaches to combat chemoresistance and improve therapeutic outcomes.

Are Raklevمشاهده پروفایل

استاد

• Theoretical Physics
• Particle Physics
• Dark Matter
• +۴ مورد دیگر

Are Raklev is a Professor at the University of Oslo's Department of Physics. His research focuses on theoretical and computational physics, particularly dark matter, particle physics at CERN's LHC, and applications of machine learning. He holds leadership roles in the GAMBIT Collaboration and its Collider Working Group. Education: PhD (University of Bergen, 2007), Postdoc (University of Cambridge, 2009), and Associate Professor at the University of Oslo (2010-2013) before becoming a full Professor in 2013. His teaching includes classical mechanics and electrodynamics (FYS3120) and supersymmetry (FYS5190/9190). Research Interests: Dark matter detection, Higgs boson studies, software for computational physics, and machine learning techniques like Gaussian processes. He leads projects like GAMBIT (a global inference tool) and PLUMBIN' (to address computational bottlenecks in high-energy physics). Recent publications span superconducting magnet design for colliders, quantum computing error correction, and nuclear isotope production. His work bridges theoretical insights with experimental applications at CERN and other facilities.

Anne Cecilie Kjeldsen Larstorpمشاهده پروفایل

دانشیار

• Hypertension Research
• Cardiovascular Medicine
• Blood Pressure Monitoring
• +۵ مورد دیگر

Anne Cecilie Kjeldsen Larstorp serves as an Associate Professor in the Department of Medical Biochemistry at the University of Oslo's Faculty of Medicine. Her work is deeply embedded in cardiovascular research with a particular focus on hypertension management, blood pressure monitoring technologies, and medication adherence. She maintains an active research presence with numerous publications spanning clinical trials, biomarker discovery, and innovative diagnostic approaches in cardiovascular medicine. Dr. Larstorp's research interests center on hypertension pathophysiology and treatment, with emphasis on medication adherence assessment through therapeutic drug monitoring, novel blood pressure monitoring technologies including cuffless devices, and cardiovascular risk assessment in hypertensive patients. Her work frequently explores gender differences in hypertension outcomes, renal denervation as a treatment approach for resistant hypertension, and biomarkers for early detection of cardiovascular and renal complications. She has made significant contributions to large-scale studies including the LIFE Study and VALUE Trial, examining long-term cardiovascular outcomes in hypertensive populations. Her recent publication trends show a strong focus on practical clinical applications, with numerous studies on the OUT-ACS and OUT-POC projects investigating rapid rule-out protocols for acute myocardial infarction in primary care settings. She has also published extensively on therapeutic drug monitoring approaches to assess medication adherence in resistant hypertension, novel biomarkers for kidney damage in hypertensive patients, and the development of advanced blood pressure monitoring technologies. Her work consistently bridges laboratory research with clinical application, demonstrating translational impact across cardiovascular medicine. Dr. Larstorp collaborates extensively with the Cardiovascular and Renal Research Group and the Internal Medicine Research Group at the University of Oslo. She is actively involved in the OUT-ACS study (Faster resolution of acute myocardial infarction at the Emergency Department in Oslo), which aims to improve diagnostic pathways for acute coronary syndromes in emergency settings. Her work frequently involves multidisciplinary collaborations with clinicians, pharmacologists, and biomedical engineers to develop and validate new approaches to hypertension management and cardiovascular risk assessment.

Kjetil Sundeمشاهده پروفایل

استاد

• Emergency Medicine
• Intensive Care Medicine
• Cardiac Arrest Management
• +۷ مورد دیگر

Kjetil Sunde is a Professor at the Department of Anesthesiology and Intensive Care Medicine , Oslo University Hospital and University of Oslo. With a career spanning over three decades, his research focuses on emergency medicine , post-resuscitation care , and traumatic brain injuries . He has led groundbreaking work in cardiac arrest management , including therapeutic hypothermia and targeted temperature management . Certified MD (1991), PhD (1999), and specialist in anesthesiology/intensive care (2000) Professor since 2009; Chief Physician at Ullevål University Hospital since 2000 His research combines clinical trials (RCTs), registry studies , and porcine animal models to explore myocardial injury , cerebral perfusion , and long-term outcomes for cardiac arrest survivors. Recent projects analyze mild hypercapnia effects and social media's role in ICU guideline adherence . He has collaborated internationally through the European Resuscitation Council (Co-Chair, 2006-2010) and European Society of Intensive Care Medicine (Chair, 2016-2019). Awards include the NAKOS Research Price (2007) , Norwegian Society of Anesthesiology Research Price (2011) , and ACTA Lecture (2019) . Key publications in Resuscitation , Critical Care Medicine , and Lancet Neurology Focus on neurological prognostication , acute kidney injury , and post-ICU psychological sequelae

• Musculoskeletal Health
• Adolescent Health
• Pain Management
• +۳ مورد دیگر

Maren Hjelle Guddal serves as a Postdoctoral Fellow at Oslo Metropolitan University's Department of Rehabilitation Science and Health Technology within the Faculty of Health Sciences. Her research centers on developing person-centered interventions to address persistent pain and disability in adolescent populations. Education: Physiotherapy Degree, Western Norway University of Applied Sciences (2006) Master's in Sports Physiotherapy, Norwegian School of Sport Sciences (2011) PhD, University of Oslo (2021) Research Focus: Dr. Guddal investigates critical intersections between physical activity, sport participation, musculoskeletal pain, and mental health in adolescents. Her work identifies modifiable risk factors for conditions like obesity and neck pain while pioneering co-developed interventions with end-users. Current emphasis targets translational pathways from epidemiological findings to clinical pain management solutions. Publication Trends: Her 2016-2023 publications reveal evolving expertise from foundational epidemiological studies on adolescent pain and sports injuries toward contemporary intervention development. Recent work demonstrates methodological progression from observational cohort analyses (HUNT/Young-HUNT studies) to pilot RCT frameworks for persistent pain management. Current Initiative: She leads the HEYoung intervention study, collaborating with adolescents, parents, and healthcare providers to co-design and pilot-test a person-centered intervention for adolescent persistent pain, preparing for full-scale randomized controlled trials. Research Context: Embedded within OsloMet's Musculoskeletal Health Research group, her work bridges clinical physiotherapy practice with population health research, leveraging prior experience from Oslo University Hospital's FORMI unit. Professional Context: With background as a practicing physiotherapist in primary/secondary care, she maintains strong clinical connections while advancing evidence-based rehabilitation science through rigorous academic research.